Seres Therapeutics
VerifiedWe are creating a new wave of medicines powered by the human microbiome.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$265m (Public information from Jul 2024)
Share price
$1.36 MCRB
Cambridge Massachusetts (HQ)
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (4 %) | 336 % | (95 %) | 1672 % | (99 %) | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (260 %) | (43 %) | (3425 %) | (75 %) | (12234 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (268 %) | (45 %) | (3509 %) | (90 %) | (15988 %) | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 273 % | 98 % | 2426 % | 115 % | - | - | - |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| investor investor investor investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
* | N/A | Post IPO Debt | |
| Total Funding | 000k | ||
Related Content
Recent News about Seres Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.